Tarveda Therapeutics Funding: $68M Raised, Series D (2017)
Tarveda Therapeutics is based in Watertown, Massachusetts. It has raised $68M in total funding. Latest round: Series D.
Tarveda Therapeutics funding overview
Tarveda Therapeutics is based in Watertown, Massachusetts. Tarveda Therapeutics has raised $68M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is a Series D announced in February 2017. The round record for Tarveda Therapeutics runs through 2017; nothing later has been disclosed. Investors on record include Versant Ventures, New Enterprise Associates, Novo A/S, NanoDimension, Flagship Pioneering. 5 distinct backers are named across the disclosed rounds.
Tarveda Therapeutics at a glance
Total raised
$68M
Latest round
Series D
Latest round date
February 2017
Headquarters
Watertown, Massachusetts
Notable investors
Versant Ventures, New Enterprise Associates, Novo A/S, NanoDimension, Flagship Pioneering
Frequently asked about Tarveda Therapeutics funding
How much has Tarveda Therapeutics raised?
Tarveda Therapeutics has raised $68M in total disclosed funding across the rounds on record.
Who has invested in Tarveda Therapeutics?
Versant Ventures, New Enterprise Associates, Novo A/S, NanoDimension, Flagship Pioneering are named among the investors backing Tarveda Therapeutics.
What was the latest Tarveda Therapeutics funding round?
The most recent disclosed round is a Series D, announced in February 2017.
Where is Tarveda Therapeutics based?
Tarveda Therapeutics is based in Watertown, Massachusetts.
When did Tarveda Therapeutics last raise?
The last disclosed Tarveda Therapeutics round closed in February 2017 at Series D.
Round data for Tarveda Therapeutics is compiled from public filings and announcements; blank fields mean nothing has been disclosed rather than nothing exists. Continue with the companies in Watertown and backer lists below.
